{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:09:56Z","timestamp":1793506196399,"version":"4.5.0"},"reference-count":209,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2022MC159"],"award-info":[{"award-number":["ZR2022MC159"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-025-02049-w","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T14:50:47Z","timestamp":1748098247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Bilirubin metabolism and its application in disease prevention: mechanisms and research advances"],"prefix":"10.1007","volume":"74","author":[{"given":"Yue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoni","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"2049_CR1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jconrel.2020.08.054","volume":"328","author":"Q Yao","year":"2020","unstructured":"Yao Q, Chen R, Ganapathy V, Kou L. Therapeutic application and construction of bilirubin incorporated nanoparticles. J Control Release. 2020;328:407\u201324.","journal-title":"J Control Release"},{"key":"2049_CR2","doi-asserted-by":"crossref","first-page":"113880","DOI":"10.1016\/j.jpeds.2023.113880","volume":"266","author":"SB Amin","year":"2024","unstructured":"Amin SB, Saluja S, Kler N. Unbound bilirubin and acute bilirubin encephalopathy in infants born late preterm and term with significant hyperbilirubinemia. J Pediatr. 2024;266:113880.","journal-title":"J Pediatr"},{"key":"2049_CR3","doi-asserted-by":"crossref","unstructured":"Paul BD, Pieper AA. Neuroprotective roles of the biliverdin Reductase-A\/Bilirubin Axis in the brain. Biomolecules 2024; 14.","DOI":"10.3390\/biom14020155"},{"key":"2049_CR4","doi-asserted-by":"crossref","unstructured":"Kipp ZA, Xu M, Bates EA, Lee WH, Kern PA, Hinds TD. Jr. Bilirubin levels are negatively correlated with adiposity in obese men and women, and its catabolized product, urobilin, is positively associated with insulin resistance. Antioxid (Basel) 2023; 12.","DOI":"10.3390\/antiox12010170"},{"key":"2049_CR5","doi-asserted-by":"crossref","unstructured":"Ullah A, Stankevic E, Holm LA, Stinson SE, Juel HB, Fonvig CE et al. Genetics of plasma bilirubin and associations between bilirubin and cardiometabolic risk profiles in Danish children and adolescents. Antioxid (Basel) 2023; 12.","DOI":"10.3390\/antiox12081613"},{"key":"2049_CR6","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.4049\/jimmunol.181.3.1887","volume":"181","author":"Y Liu","year":"2008","unstructured":"Liu Y, Li P, Lu J, Xiong W, Oger J, Tetzlaff W, et al. Bilirubin possesses powerful Immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis. J Immunol. 2008;181:1887\u201397.","journal-title":"J Immunol"},{"key":"2049_CR7","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0006-2952(95)02395-X","volume":"51","author":"T-W Wu","year":"1996","unstructured":"Wu T-W, Fung KP, Wu J, Yang C-C, Weisel RD. Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol. 1996;51:859\u201362.","journal-title":"Biochem Pharmacol"},{"key":"2049_CR8","doi-asserted-by":"crossref","first-page":"109199","DOI":"10.1016\/j.thromres.2024.109199","volume":"244","author":"SK Manikanta, NaveenKumar","year":"2024","unstructured":"Manikanta, NaveenKumar SK, Thushara RM, Hemshekhar M, Sumedini ML, Sunitha K, et al. Counteraction of unconjugated bilirubin against heme-induced toxicity in platelets. Thromb Res. 2024;244:109199.","journal-title":"Thromb Res"},{"key":"2049_CR9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","volume":"54","author":"P Libby","year":"2009","unstructured":"Libby P, Ridker PM, Hansson GK, Atherothrombosis, LTNo. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54:2129\u201338.","journal-title":"J Am Coll Cardiol"},{"key":"2049_CR10","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.1152\/ajpendo.00405.2020","volume":"320","author":"JF Creeden","year":"2021","unstructured":"Creeden JF, Gordon DM, Stec DE, Hinds TD. Jr. Bilirubin as a metabolic hormone: the physiological relevance of low levels. Am J Physiol Endocrinol Metab. 2021;320:E191\u2013207.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2049_CR11","unstructured":"Kalakonda A, Jenkins BA, John S, Physiology. Bilirubin: StatPearls Publishing, Treasure Island (FL), 2023."},{"key":"2049_CR12","first-page":"1","volume-title":"Heme degradation and bilirubin formation","author":"S Brown","year":"2018","unstructured":"Brown S, Troxler R. Heme degradation and bilirubin formation. Bilirubin: CRC; 2018. pp. 1\u201338."},{"key":"2049_CR13","doi-asserted-by":"crossref","unstructured":"Adin CA. Bilirubin as a therapeutic molecule: challenges and opportunities. Antioxid (Basel) 2021; 10.","DOI":"10.3390\/antiox10101536"},{"key":"2049_CR14","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1089\/ars.2007.1807","volume":"9","author":"R \u00d6llinger","year":"2007","unstructured":"\u00d6llinger R, Wang H, Yamashita K, Wegiel B, Thomas M, Margreiter R, et al. Therapeutic applications of bilirubin and biliverdin in transplantation. Antioxid Redox Signal. 2007;9:2175\u201386.","journal-title":"Antioxid Redox Signal"},{"key":"2049_CR15","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1016\/S0021-9258(18)32411-6","volume":"258","author":"J Jacobsen","year":"1983","unstructured":"Jacobsen J, Brodersen R. Albumin-bilirubin binding mechanism. J Biol Chem. 1983;258:6319\u201326.","journal-title":"J Biol Chem"},{"key":"2049_CR16","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/biomedicines13020302","volume":"13","author":"KI Williams","year":"2025","unstructured":"Williams KI, Suryadevara P, Zhan C-G, Hinds TD, Kipp ZA. Urobilin derived from bilirubin bioconversion binds albumin and May interfere with bilirubin interacting with albumin: implications for disease pathology. Biomedicines. 2025;13:302.","journal-title":"Biomedicines"},{"key":"2049_CR17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000457308","volume":"6","author":"R Brodersen","year":"2017","unstructured":"Brodersen R, Friis-Hansen B, Stern L. Drug-Induced displacement of bilirubin from albumin in the newborn. Dev Pharmacol Ther. 2017;6:217\u201329.","journal-title":"Dev Pharmacol Ther"},{"key":"2049_CR18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1201\/9781351070119-2","volume-title":"Aspects of bilirubin transport","author":"JA Meuwissen","year":"2018","unstructured":"Meuwissen JA, Heirwegh KP. Aspects of bilirubin transport. Bilirubin: CRC; 2018. pp. 39\u201384."},{"key":"2049_CR19","doi-asserted-by":"crossref","unstructured":"\u010cvorovi\u0107 J, Passamonti S. Membrane transporters for bilirubin and its conjugates: A systematic review. Front Pharmacol 2017; 8.","DOI":"10.3389\/fphar.2017.00887"},{"key":"2049_CR20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cupe.2005.10.002","volume":"16","author":"X Wang","year":"2006","unstructured":"Wang X, Chowdhury JR, Chowdhury NR. Bilirubin metabolism: applied physiology. Curr Paediatrics. 2006;16:70\u20134.","journal-title":"Curr Paediatrics"},{"key":"2049_CR21","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1152\/physrev.00004.2019","volume":"100","author":"TWR Hansen","year":"2020","unstructured":"Hansen TWR, Wong RJ, Stevenson DK. Molecular physiology and pathophysiology of bilirubin handling by the blood, liver, intestine, and brain in the newborn. Physiol Rev. 2020;100:1291\u2013346.","journal-title":"Physiol Rev"},{"key":"2049_CR22","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.3390\/nu13124259","volume":"13","author":"N Iyer","year":"2021","unstructured":"Iyer N, Corr SC. Gut microbial Metabolite-Mediated regulation of the intestinal barrier in the pathogenesis of inflammatory bowel disease. Nutrients. 2021;13:4259.","journal-title":"Nutrients"},{"key":"2049_CR23","first-page":"352","volume":"2","author":"AR Guerra Ruiz","year":"2021","unstructured":"Guerra Ruiz AR, Crespo J, Lopez Martinez RM, Iruzubieta P, Casals Mercadal G, Lalana Garces M, et al. Measurement and clinical usefulness of bilirubin in liver disease. Adv Lab Med. 2021;2:352\u201372.","journal-title":"Adv Lab Med"},{"key":"2049_CR24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.molmed.2023.01.007","volume":"29","author":"L Vitek","year":"2023","unstructured":"Vitek L, Hinds TD Jr., Stec DE, Tiribelli C. The physiology of bilirubin: health and disease equilibrium. Trends Mol Med. 2023;29:315\u201328.","journal-title":"Trends Mol Med"},{"key":"2049_CR25","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jhep.2021.06.010","volume":"75","author":"L V\u00edtek","year":"2021","unstructured":"V\u00edtek L, Tiribelli C. Bilirubin: the yellow hormone? J Hepatol. 2021;75:1485\u201390.","journal-title":"J Hepatol"},{"key":"2049_CR26","doi-asserted-by":"crossref","unstructured":"Jayanti S, Vitek L, Tiribelli C, Gazzin S. The role of bilirubin and the other yellow players in neurodegenerative diseases. Antioxid (Basel) 2020; 9.","DOI":"10.20517\/2347-8659.2019.14"},{"key":"2049_CR27","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2174\/1381612823666170113153818","volume":"23","author":"JF Ndisang","year":"2017","unstructured":"Ndisang JF. Synergistic interaction between Heme Oxygenase (HO) and Nuclear-Factor E2- related Factor-2 (Nrf2) against oxidative stress in cardiovascular related diseases. Curr Pharm Des. 2017;23:1465\u201370.","journal-title":"Curr Pharm Des"},{"key":"2049_CR28","doi-asserted-by":"crossref","unstructured":"Jansen PL. Jaundice and cholestasis. Sherlock\u2019s Diseases of the Liver and Biliary System 2018:231\u2013255.","DOI":"10.1002\/9781119237662.ch13"},{"key":"2049_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03602532.2021.2001493","volume":"54","author":"D Liu","year":"2022","unstructured":"Liu D, Yu Q, Ning Q, Liu Z, Song J. The relationship between UGT1A1 gene & various diseases and prevention strategies. Drug Metab Rev. 2022;54:1\u201321.","journal-title":"Drug Metab Rev"},{"key":"2049_CR30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41564-023-01549-x","volume":"9","author":"B Hall","year":"2024","unstructured":"Hall B, Levy S, Dufault-Thompson K, Arp G, Zhong A, Ndjite GM, et al. BilR is a gut microbial enzyme that reduces bilirubin to urobilinogen. Nat Microbiol. 2024;9:173\u201384.","journal-title":"Nat Microbiol"},{"key":"2049_CR31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/21678707.2018.1495558","volume":"6","author":"G Bortolussi","year":"2018","unstructured":"Bortolussi G, Muro AF. Advances in Understanding disease mechanisms and potential treatments for Crigler\u2013Najjar syndrome. Expert Opin Orphan Drugs. 2018;6:425\u201339.","journal-title":"Expert Opin Orphan Drugs"},{"key":"2049_CR32","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.3390\/molecules26102975","volume":"26","author":"DM Gordon","year":"2021","unstructured":"Gordon DM, Hong SH, Kipp ZA, Hinds TD. Identification of binding regions of bilirubin in the Ligand-Binding pocket of the peroxisome Proliferator-Activated Receptor-A (PPARalpha). Molecules. 2021;26:2975.","journal-title":"Molecules"},{"key":"2049_CR33","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/med.21660","volume":"40","author":"L Vitek","year":"2020","unstructured":"Vitek L. Bilirubin as a signaling molecule. Med Res Rev. 2020;40:1335\u201351.","journal-title":"Med Res Rev"},{"key":"2049_CR34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/abbi.1998.0814","volume":"357","author":"D Phelan","year":"1998","unstructured":"Phelan D, Winter G, Rogers W, Lam J, Denison M. Activation of the ah receptor signal transduction pathway by bilirubin and biliverdin. Arch Biochem Biophys. 1998;357:155\u201363.","journal-title":"Arch Biochem Biophys"},{"key":"2049_CR35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrd753","volume":"1","author":"TM Willson","year":"2002","unstructured":"Willson TM, Kliewer SA, PXR. CAR and drug metabolism. Nat Rev Drug Discovery. 2002;1:259\u201366.","journal-title":"Nat Rev Drug Discovery"},{"key":"2049_CR36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s13238-013-0013-0","volume":"5","author":"H Yang","year":"2014","unstructured":"Yang H, Wang H. Signaling control of the constitutive Androstane receptor (CAR). Protein Cell. 2014;5:113\u201323.","journal-title":"Protein Cell"},{"key":"2049_CR37","first-page":"956","volume":"1812","author":"CA Ihunnah","year":"2011","unstructured":"Ihunnah CA, Jiang M, Xie W. Nuclear receptor PXR, transcriptional circuits and metabolic relevance. Biochim Et Biophys Acta (BBA)-Molecular Basis Disease. 2011;1812:956\u201363.","journal-title":"Biochim Et Biophys Acta (BBA)-Molecular Basis Disease"},{"key":"2049_CR38","doi-asserted-by":"crossref","unstructured":"Huang W, Zhang J, Chua SS, Qatanani M, Han Y, Granata R et al. Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proceedings of the National Academy of Sciences. 2003; 100:4156\u20134161.","DOI":"10.1073\/pnas.0630614100"},{"key":"2049_CR39","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.3390\/molecules24142545","volume":"24","author":"F Hong","year":"2019","unstructured":"Hong F, Pan S, Guo Y, Xu P, Zhai Y. PPARs as nuclear receptors for nutrient and energy metabolism. Molecules. 2019;24:2545.","journal-title":"Molecules"},{"key":"2049_CR40","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.2174\/138161209789058237","volume":"15","author":"L Vitek","year":"2009","unstructured":"Vitek L, Ostrow JD. Bilirubin chemistry and metabolism; harmful and protective aspects. Curr Pharm Design. 2009;15:2869\u201383.","journal-title":"Curr Pharm Design"},{"key":"2049_CR41","unstructured":"Dillon J. The liver, regulator of nutrition. Children in the Tropics; 1995."},{"key":"2049_CR42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.molmed.2008.12.004","volume":"15","author":"MP Soares","year":"2009","unstructured":"Soares MP, Bach FH. Heme oxygenase-1: from biology to therapeutic potential. Trends Mol Med. 2009;15:50\u20138.","journal-title":"Trends Mol Med"},{"key":"2049_CR43","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.bbrc.2006.03.036","volume":"343","author":"M Hsu","year":"2006","unstructured":"Hsu M, Muchova L, Morioka I, Wong RJ, Schr\u00f6der H, Stevenson DK. Tissue-specific effects of Statins on the expression of Heme oxygenase-1 in vivo. Biochem Biophys Res Commun. 2006;343:738\u201344.","journal-title":"Biochem Biophys Res Commun"},{"key":"2049_CR44","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.tiv.2014.05.016","volume":"28","author":"M Szab\u00f3","year":"2014","unstructured":"Szab\u00f3 M, Veres Z, B\u00e1tai-Konczos A, K\u00e9kesi O, Kis E, Szab\u00f3 K, et al. Statins alter the hepatobiliary transport of unconjugated and conjugated bilirubin in sandwich-cultured rat hepatocytes. Toxicol in Vitro. 2014;28:1136\u201343.","journal-title":"Toxicol in Vitro"},{"key":"2049_CR45","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/17425255.2020.1779701","volume":"16","author":"J Wang","year":"2020","unstructured":"Wang J, Bwayi M, Gee RRF, Chen T. PXR-mediated idiosyncratic drug-induced liver injury: mechanistic insights and targeting approaches. Expert Opin Drug Metab Toxicol. 2020;16:711\u201322.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2049_CR46","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s11095-010-0117-7","volume":"27","author":"S Mukherjee","year":"2010","unstructured":"Mukherjee S, Mani S. Orphan nuclear receptors as targets for drug development. Pharm Res. 2010;27:1439\u201368.","journal-title":"Pharm Res"},{"key":"2049_CR47","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1089\/ars.2004.6.841","volume":"6","author":"R Stocker","year":"2004","unstructured":"Stocker R. Antioxidant activities of bile pigments. Antioxid Redox Signal. 2004;6:841\u20139.","journal-title":"Antioxid Redox Signal"},{"key":"2049_CR48","first-page":"e18","volume":"119","author":"CP Soto Conti","year":"2021","unstructured":"Soto Conti CP, Bilirubin. The toxic mechanisms of an antioxidant molecule. Arch Argent Pediatr. 2021;119:e18\u201325.","journal-title":"Arch Argent Pediatr"},{"key":"2049_CR49","doi-asserted-by":"crossref","unstructured":"Parthasarathy S, Raghavamenon A, Garelnabi MO, Santanam N. Oxidized low-density lipoprotein. Free Radicals Antioxid Protocols 2010:403\u201317.","DOI":"10.1007\/978-1-60327-029-8_24"},{"key":"2049_CR50","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1007\/s12035-018-1440-y","volume":"56","author":"M Thakkar","year":"2019","unstructured":"Thakkar M, Edelenbos J, Dore S. Bilirubin and ischemic stroke: rendering the current paradigm to better understand the protective effects of bilirubin. Mol Neurobiol. 2019;56:5483\u201396.","journal-title":"Mol Neurobiol"},{"key":"2049_CR51","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1073\/pnas.0813132106","volume":"106","author":"TW Sedlak","year":"2009","unstructured":"Sedlak TW, Saleh M, Higginson DS, Paul BD, Juluri KR, Snyder SH. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci. 2009;106:5171\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"2049_CR52","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.atherosclerosis.2014.05.927","volume":"235","author":"E Oda","year":"2014","unstructured":"Oda E. A decrease in total bilirubin predicted hyper-LDL cholesterolemia in a health screening population. Atherosclerosis. 2014;235:334\u20138.","journal-title":"Atherosclerosis"},{"key":"2049_CR53","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3390\/molecules24081583","volume":"24","author":"A Singh","year":"2019","unstructured":"Singh A, Kukreti R, Saso L, Kukreti S. Oxidative stress: a key modulator in neurodegenerative diseases. Molecules. 2019;24:1583.","journal-title":"Molecules"},{"key":"2049_CR54","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMra1308124","volume":"369","author":"JF Watchko","year":"2013","unstructured":"Watchko JF, Tiribelli C. Bilirubin-induced neurologic damage\u2014mechanisms and management approaches. N Engl J Med. 2013;369:2021\u201330.","journal-title":"N Engl J Med"},{"key":"2049_CR55","doi-asserted-by":"crossref","unstructured":"Jayanti S, Moretti R, Tiribelli C, Gazzin S. Bilirubin and inflammation in neurodegenerative and other neurological diseases. Neuroimmunology and Neuroinflammation. 2020; 2020.","DOI":"10.20517\/2347-8659.2019.14"},{"key":"2049_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.04.011","volume":"133","author":"JY Kim","year":"2017","unstructured":"Kim JY, Lee DY, Kang S, Miao W, Kim H, Lee Y, et al. Bilirubin nanoparticle preconditioning protects against hepatic ischemia-reperfusion injury. Biomaterials. 2017;133:1\u201310.","journal-title":"Biomaterials"},{"key":"2049_CR57","doi-asserted-by":"crossref","first-page":"599","DOI":"10.5009\/gnl20171","volume":"15","author":"HA Lee","year":"2021","unstructured":"Lee HA, Jung JY, Lee YS, Jung YK, Kim JH, An H, et al. Direct bilirubin is more valuable than total bilirubin for predicting prognosis in patients with liver cirrhosis. Gut Liver. 2021;15:599\u2013605.","journal-title":"Gut Liver"},{"key":"2049_CR58","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/antiox10030364","volume":"10","author":"M Vairetti","year":"2021","unstructured":"Vairetti M, Di Pasqua LG, Cagna M, Richelmi P, Ferrigno A, Berardo C. Changes in glutathione content in liver diseases: an update. Antioxidants. 2021;10:364.","journal-title":"Antioxidants"},{"key":"2049_CR59","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.3390\/molecules29194576","volume":"29","author":"AM Garc\u00eda-Mu\u00f1oz","year":"2024","unstructured":"Garc\u00eda-Mu\u00f1oz AM, Victoria-Montesinos D, Ballester P, Cerd\u00e1 B, Zafrilla P. A descriptive review of the antioxidant effects and mechanisms of action of Berberine and Silymarin. Molecules. 2024;29:4576.","journal-title":"Molecules"},{"key":"2049_CR60","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","volume":"13","author":"T Kawai","year":"2007","unstructured":"Kawai T, Akira S. Signaling to NF-\u03baB by Toll-like receptors. Trends Mol Med. 2007;13:460\u20139.","journal-title":"Trends Mol Med"},{"key":"2049_CR61","doi-asserted-by":"crossref","unstructured":"Tanaka T, Narazaki M, Kishimoto T. Interleukin (IL-6) immunotherapy. Cold Spring Harbor perspectives in biology. 2018; 10:a028456.","DOI":"10.1101\/cshperspect.a028456"},{"key":"2049_CR62","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00702-017-1732-9","volume":"125","author":"AS Mendiola","year":"2018","unstructured":"Mendiola AS, Cardona AE. The IL-1\u03b2 phenomena in neuroinflammatory diseases. J Neural Transm. 2018;125:781\u201395.","journal-title":"J Neural Transm"},{"key":"2049_CR63","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cell.2010.11.019","volume":"143","author":"D Ribet","year":"2010","unstructured":"Ribet D, Cossart P. Pathogen-mediated posttranslational modifications: a re-emerging field. Cell. 2010;143:694\u2013702.","journal-title":"Cell"},{"key":"2049_CR64","doi-asserted-by":"crossref","first-page":"106520","DOI":"10.1016\/j.intimp.2020.106520","volume":"84","author":"Y Li","year":"2020","unstructured":"Li Y, Huang B, Ye T, Wang Y, Xia D, Qian J. Physiological concentrations of bilirubin control inflammatory response by inhibiting NF-kappaB and inflammasome activation. Int Immunopharmacol. 2020;84:106520.","journal-title":"Int Immunopharmacol"},{"key":"2049_CR65","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.neuron.2023.02.022","volume":"111","author":"HW Liu","year":"2023","unstructured":"Liu HW, Gong LN, Lai K, Yu XF, Liu ZQ, Li MX, et al. Bilirubin gates the TRPM2 channel as a direct agonist to exacerbate ischemic brain damage. Neuron. 2023;111:1609\u2013e16256.","journal-title":"Neuron"},{"key":"2049_CR66","doi-asserted-by":"crossref","first-page":"13292","DOI":"10.3390\/ijms252413292","volume":"25","author":"S Thangasparan","year":"2024","unstructured":"Thangasparan S, Kamisah Y, Ugusman A, Mohamad Anuar NN, Ibrahim NI. Unravelling the mechanisms of oxidised Low-Density lipoprotein in cardiovascular health: current evidence from in vitro and in vivo studies. Int J Mol Sci. 2024;25:13292.","journal-title":"Int J Mol Sci"},{"key":"2049_CR67","unstructured":"Ying L, Yuhua L, Xiang C. Immunologic mechanisms and treatment of acute coronary syndromes. Chin Med J 2006."},{"key":"2049_CR68","unstructured":"Ko I, Koutaro Y. Is obesity an absolute evil? Increase in adipose tissue does not always decrease insulin sensitivity. J Diabetes Invest 2014."},{"key":"2049_CR69","unstructured":"Ying-Zheng Z, Zhiwei H, Yuanyuan Z, Yannan S, Chu-Chu D, Jiaoyuan Z et al. Polylysine-bilirubin conjugates maintain functional Islets and promote M2 macrophage polarization. Acta Biomater 2021."},{"key":"2049_CR70","unstructured":"Lauren RF, Sabine M, Corri BL, Bethany PC, Joseph JW. Increasing body condition score is positively associated interleukin-6 and monocyte chemoattractant protein-1 in Labrador retrievers. Veterinary Immunology and Immunopathology; 2015."},{"key":"2049_CR71","doi-asserted-by":"crossref","first-page":"e0223302","DOI":"10.1371\/journal.pone.0223302","volume":"14","author":"R Takei","year":"2019","unstructured":"Takei R, Inoue T, Sonoda N, Kohjima M, Okamoto M, Sakamoto R, et al. Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines. PLoS ONE. 2019;14:e0223302.","journal-title":"PLoS ONE"},{"key":"2049_CR72","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/imm.12336","volume":"143","author":"FP Castro-Garc\u00eda","year":"2014","unstructured":"Castro-Garc\u00eda FP, Corral\u2010Jara KF, Escobedo\u2010Melendez G, Sandoval\u2010Hernandez MA, Rosenstein Y, Roman S, et al. Conjugated bilirubin affects cytokine profiles in hepatitis A virus infection by modulating function of signal transducer and activator of transcription factors. Immunology. 2014;143:578\u201387.","journal-title":"Immunology"},{"key":"2049_CR73","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jocn.2011.02.023","volume":"18","author":"F Peng","year":"2011","unstructured":"Peng F, Deng X, Yu Y, Chen X, Shen L, Zhong X, et al. Serum bilirubin concentrations and multiple sclerosis. J Clin Neurosci. 2011;18:1355\u20139.","journal-title":"J Clin Neurosci"},{"key":"2049_CR74","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/IJGM.S393273","volume":"16","author":"H Zhang","year":"2023","unstructured":"Zhang H, Yang G, Jiang R, Feng D, Li Y, Chen Y, et al. Correlation between total bilirubin, total bilirubin\/albumin ratio with disease activity in patients with rheumatoid arthritis. Int J Gen Med. 2023;16:273\u201380.","journal-title":"Int J Gen Med"},{"key":"2049_CR75","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jconrel.2021.01.019","volume":"331","author":"TW Kim","year":"2021","unstructured":"Kim TW, Kim Y, Jung W, Kim DE, Keum H, Son Y, et al. Bilirubin nanomedicine ameliorates the progression of experimental autoimmune encephalomyelitis by modulating dendritic cells. J Control Release. 2021;331:74\u201384.","journal-title":"J Control Release"},{"key":"2049_CR76","unstructured":"Jieyun X, Kai Z, Kailin X. Research progress on the role of autoimmune regulator in immunological tolerance formation. Int J Immunol 2017."},{"key":"2049_CR77","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3389\/fimmu.2019.01765","volume":"10","author":"GR Lee","year":"2019","unstructured":"Lee GR, Shaefi S, Otterbein LE. HO-1 and CD39: it takes two to protect the realm. Front Immunol. 2019;10:1765.","journal-title":"Front Immunol"},{"key":"2049_CR78","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/annonc\/mdx281","volume":"28","author":"S Dueland","year":"2017","unstructured":"Dueland S, Guren T, Boberg K, Reims H, Grzyb K, Aamdal S, et al. Acute liver graft rejection after ipilimumab therapy. Ann Oncol. 2017;28:2619\u201320.","journal-title":"Ann Oncol"},{"key":"2049_CR79","unstructured":"Hang L, Weimin L, Haorun L, Ruiguan W, Hong Z. Correlation of peripheral blood bilirubin level with Tregs in patients with bile duct stones. Chin J Hepatobiliary Surg 2016."},{"key":"2049_CR80","doi-asserted-by":"crossref","first-page":"8650","DOI":"10.3390\/ijms21228650","volume":"21","author":"DT Tran","year":"2020","unstructured":"Tran DT, Jeong YY, Kim JM, Bae HB, Son SK, Kwak SH. The anti-inflammatory role of bilirubin on two-hit sepsis animal model. Int J Mol Sci. 2020;21:8650.","journal-title":"Int J Mol Sci"},{"key":"2049_CR81","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/eci.12120","volume":"43","author":"M Wallner","year":"2013","unstructured":"Wallner M, Bulmer AC, M\u00f6lzer C, M\u00fcllner E, Marculescu R, Doberer D, et al. Haem catabolism: a novel modulator of inflammation in G Ilbert\u2019s syndrome. Eur J Clin Invest. 2013;43:912\u20139.","journal-title":"Eur J Clin Invest"},{"key":"2049_CR82","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/CS20120661","volume":"125","author":"M Wallner","year":"2013","unstructured":"Wallner M, Marculescu R, Doberer D, Wolzt M, Wagner O, Vitek L, et al. Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert\u2019s syndrome. Clin Sci. 2013;125:257\u201364.","journal-title":"Clin Sci"},{"key":"2049_CR83","doi-asserted-by":"crossref","first-page":"594574","DOI":"10.3389\/fphar.2020.594574","volume":"11","author":"TD Hinds Jr","year":"2020","unstructured":"Hinds TD Jr, Creeden JF, Gordon DM, Stec DF, Donald MC, Stec DE. Bilirubin nanoparticles reduce diet-induced hepatic steatosis, improve fat utilization, and increase plasma \u03b2-hydroxybutyrate. Front Pharmacol. 2020;11:594574.","journal-title":"Front Pharmacol"},{"key":"2049_CR84","doi-asserted-by":"crossref","unstructured":"Zhu Y-D, Guan X-Q, Chen J, Peng S, Finel M, Zhao Y-Y et al. Neobavaisoflavone induces bilirubin metabolizing enzyme UGT1A1 via PPAR\u03b1 and PPAR\u03b3. Front Pharmacol 2021; 11.","DOI":"10.3389\/fphar.2020.628314"},{"key":"2049_CR85","unstructured":"Darren MG, Scott M, Robert EM, David ES, Terry DH. Bilirubin: A Fat Busting Metabolic Hormone? The FASEB Journal 2020."},{"key":"2049_CR86","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1074\/jbc.RA120.013700","volume":"295","author":"DM Gordon","year":"2020","unstructured":"Gordon DM, Neifer KL, Hamoud A-RA, Hawk CF, Nestor-Kalinoski AL, Miruzzi SA, et al. Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator\u2013activated receptor \u03b1. J Biol Chem. 2020;295:9804\u201322.","journal-title":"J Biol Chem"},{"key":"2049_CR87","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.nutr.27.061406.093710","volume":"28","author":"J Storch","year":"2008","unstructured":"Storch J, Corsico B. The emerging functions and mechanisms of mammalian fatty acid\u2013binding proteins. Annu Rev Nutr. 2008;28:73\u201395.","journal-title":"Annu Rev Nutr"},{"key":"2049_CR88","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrendo.2015.122","volume":"11","author":"GS Hotamisligil","year":"2015","unstructured":"Hotamisligil GS, Bernlohr DA. Metabolic functions of FABPs\u2014mechanisms and therapeutic implications. Nat Reviews Endocrinol. 2015;11:592\u2013605.","journal-title":"Nat Reviews Endocrinol"},{"key":"2049_CR89","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1073\/pnas.051619898","volume":"98","author":"C Wolfrum","year":"2001","unstructured":"Wolfrum C, Borrmann CM, B\u00f6rchers T, Spener F. Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors \u03b1-and \u03b3-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. Proc Natl Acad Sci. 2001;98:2323\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"2049_CR90","first-page":"17","volume":"1","author":"G Perdomo","year":"2008","unstructured":"Perdomo G, Dong HH. Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging. Aging (Albany N Y). 2008;1:17.","journal-title":"Aging (Albany N Y)"},{"key":"2049_CR91","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1073\/pnas.071056198","volume":"98","author":"EA Thomas","year":"2001","unstructured":"Thomas EA, Dean B, Pavey G, Sutcliffe JG. Increased CNS levels of Apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders. Proc Natl Acad Sci. 2001;98:4066\u201371.","journal-title":"Proc Natl Acad Sci"},{"key":"2049_CR92","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1471-4159.2011.07266.x","volume":"117","author":"R Bajo-Gra\u00f1eras","year":"2011","unstructured":"Bajo-Gra\u00f1eras R, Sanchez D, Gutierrez G, Gonz\u00e1lez C, Do Carmo S, Rassart E, et al. Apolipoprotein D alters the early transcriptional response to oxidative stress in the adult cerebellum. J Neurochem. 2011;117:949\u201360.","journal-title":"J Neurochem"},{"key":"2049_CR93","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1096\/fj.201700374R","volume":"31","author":"CJ Lai","year":"2017","unstructured":"Lai CJ, Cheng HC, Lin CY, Huang SH, Chen TH, Chung CJ, et al. Activation of liver X receptor suppresses angiogenesis via induction of apod. FASEB J. 2017;31:5568\u201376.","journal-title":"FASEB J"},{"key":"2049_CR94","unstructured":"Brigitta S, Kathleen S, Emma W. AHR in the intestinal microenvironment: safeguarding barrier function. Nat Rev Gastroenterol Hepatol 2021."},{"key":"2049_CR95","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.aohep.2019.02.001","volume":"18","author":"L Vitek","year":"2019","unstructured":"Vitek L, Hubacek JA, Pajak A, Dory\u0144ska A, Kozela M, Eremiasova L, et al. Association between plasma bilirubin and mortality. Ann Hepatol. 2019;18:379\u201385.","journal-title":"Ann Hepatol"},{"key":"2049_CR96","unstructured":"Kenison-White JE. The role of the Aryl hydrocarbon receptor in autoimmunity and tumor immunity. Boston University; 2021."},{"key":"2049_CR97","first-page":"645","volume":"391","author":"KW Bock","year":"2010","unstructured":"Bock KW, K\u00f6hle C. Contributions of the ah receptor to bilirubin homeostasis and its antioxidative and atheroprotective functions. Biol Chem. 2010;391:645\u201353.","journal-title":"Biol Chem"},{"key":"2049_CR98","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bcp.2008.11.021","volume":"77","author":"NI Kerkvliet","year":"2009","unstructured":"Kerkvliet NI. AHR-mediated Immunomodulation: the role of altered gene transcription. Biochem Pharmacol. 2009;77:746\u201360.","journal-title":"Biochem Pharmacol"},{"key":"2049_CR99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20140566","volume":"129","author":"K-H Wagner","year":"2015","unstructured":"Wagner K-H, Wallner M, M\u00f6lzer C, Gazzin S, Bulmer AC, Tiribelli C, et al. Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases. Clin Sci. 2015;129:1\u201325.","journal-title":"Clin Sci"},{"key":"2049_CR100","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.molmed.2016.07.004","volume":"22","author":"S Gazzin","year":"2016","unstructured":"Gazzin S, Vitek L, Watchko J, Shapiro SM, Tiribelli C. A novel perspective on the biology of bilirubin in health and disease. Trends Mol Med. 2016;22:758\u201368.","journal-title":"Trends Mol Med"},{"key":"2049_CR101","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-genet-120116-024723","volume":"51","author":"J Meixiong","year":"2017","unstructured":"Meixiong J, Dong X. Mas-related G protein\u2013coupled receptors and the biology of itch sensation. Annu Rev Genet. 2017;51:103\u201321.","journal-title":"Annu Rev Genet"},{"key":"2049_CR102","doi-asserted-by":"crossref","first-page":"e44116","DOI":"10.7554\/eLife.44116","volume":"8","author":"J Meixiong","year":"2019","unstructured":"Meixiong J, Vasavda C, Green D, Zheng Q, Qi L, Kwatra SG, et al. Identification of a bilirubin receptor that May mediate a component of cholestatic itch. Elife. 2019;8:e44116.","journal-title":"Elife"},{"key":"2049_CR103","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/bs.ai.2017.06.002","volume":"136","author":"H Ali","year":"2017","unstructured":"Ali H. Emerging roles for MAS-related G protein-coupled receptor-X2 in host defense peptide, opioid, and neuropeptide-mediated inflammatory reactions. Adv Immunol. 2017;136:123\u201362.","journal-title":"Adv Immunol"},{"key":"2049_CR104","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11010-008-9884-4","volume":"319","author":"F Gembardt","year":"2008","unstructured":"Gembardt F, Grajewski S, Vahl M, Schultheiss H-P, Walther T. Angiotensin metabolites can stimulate receptors of the Mas-related genes family. Mol Cell Biochem. 2008;319:115\u201323.","journal-title":"Mol Cell Biochem"},{"key":"2049_CR105","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1097\/01.hjh.0000500142.68879.05","volume":"34","author":"K Murakami","year":"2016","unstructured":"Murakami K, Fukuoka T, PS 02\u201313 ANTI-ATHEROSCLEROTIC EFFECT OF MILD BILIRUBIN ELEVATION IS MASKED BY THE CONFOUNDING FACTOR OF FATTY LIVER AND ABDOMINAL OBESITY IN THE APPARENTLY HEALTHY JAPANESE MIDDLE-AGED PEOPLE. J Hypertens. 2016;34:e107\u20138.","journal-title":"J Hypertens"},{"key":"2049_CR106","doi-asserted-by":"crossref","first-page":"A13417","DOI":"10.1161\/circ.146.suppl_1.13417","volume":"146","author":"BJ Pullen","year":"2022","unstructured":"Pullen BJ, Vidanapathirana AK, Sandeman L, Everest-Dass A, Kolarich D, Tan JT, et al. Deletion of the Asialyloglycoprotein Receptor-1 causes Athero-Protective effects in vitro and in vivo. Circulation. 2022;146:A13417\u201313417.","journal-title":"Circulation"},{"key":"2049_CR107","unstructured":"Masako S, Akiko H, Toshiko M, Mayu H, Yutaka M, Mizutani S et al. Isohumulones modulate blood lipid status through the activation of PPAR\u03b1. Biochim Biophys Acta 2005."},{"key":"2049_CR108","unstructured":"Sihao L, Brown J, Kristopher JS, Edwin AH, Mathias L, Karen I et al. A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use. Nature 2013."},{"key":"2049_CR109","unstructured":"Alexandra R. Characterisation of the role of RUNX1 in the context of myocardial ischaemia-reperfusion injury. null. 2020."},{"key":"2049_CR110","unstructured":"Victor AF, Commentary. Recovering ischemic myocardium\u2014hibernation, autophagy, preconditioning, mitochondria, stem cells, and more. The Journal of Thoracic and Cardiovascular Surgery; 2021."},{"key":"2049_CR111","doi-asserted-by":"crossref","first-page":"e021212","DOI":"10.1161\/JAHA.121.021212","volume":"10","author":"W Ai","year":"2021","unstructured":"Ai W, Bae S, Ke Q, Su S, Li R, Chen Y, et al. Bilirubin nanoparticles protect against cardiac ischemia\/reperfusion injury in mice. J Am Heart Assoc. 2021;10:e021212.","journal-title":"J Am Heart Assoc"},{"key":"2049_CR112","unstructured":"Ruiqi Z, Li L, Ba DN, Amy SD, Donald S. Gilteritinib and Venetoclax Synergize to Eliminate FLT3\/ITD\u2009+\u2009Leukemia Cells through BIM. Blood. 2019."},{"key":"2049_CR113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2369-14-1","volume":"14","author":"SW Oh","year":"2013","unstructured":"Oh SW, Lee ES, Kim S, Na KY, Chae DW, Kim S, et al. Bilirubin attenuates the renal tubular injury by Inhibition of oxidative stress and apoptosis. BMC Nephrol. 2013;14:1\u201312.","journal-title":"BMC Nephrol"},{"key":"2049_CR114","unstructured":"Nguyen TMT. Non-canonical roles of the anti-apoptotic protein Bcl-xL in the development of the central nervous system. Universit\u00e9 Claude Bernard-Lyon I; 2022."},{"key":"2049_CR115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fphys.2014.00053","volume":"5","author":"R Ben-Amotz","year":"2014","unstructured":"Ben-Amotz R, Bonagura J, Velayutham M, Hamlin R, Burns P, Adin C. Intraperitoneal bilirubin administration decreases infarct area in a rat coronary ischemia\/reperfusion model. Front Physiol. 2014;5:53.","journal-title":"Front Physiol"},{"key":"2049_CR116","doi-asserted-by":"crossref","unstructured":"Vitek L, Jiraskova A, Malikova I, Dostalova G, Eremiasova L, Danzig V et al. Serum bilirubin and markers of oxidative stress and inflammation in a healthy population and in patients with various forms of atherosclerosis. Antioxid (Basel) 2022; 11.","DOI":"10.3390\/antiox11112118"},{"key":"2049_CR117","unstructured":"Xiruo L, Dongyan Z, Leigh G, Sandro Massao H, Ye Z, Rachel JP, et al. Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice. Proceedings of the National Academy of Sciences of the United States of America; 2020."},{"key":"2049_CR118","unstructured":"Aleyda BA, Elena RL, Olga B, L\u00eddia C, \u00c0ngela V, Laura H, et al. Low-density lipoprotein receptor-related protein 1 deficiency in cardiomyocytes reduces susceptibility to insulin resistance and obesity. Metabolism; 2020."},{"key":"2049_CR119","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.freeradbiomed.2024.09.023","volume":"224","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Chen Y, Chen X, Gao Y, Luo J, Lu S, et al. Unconjugated bilirubin promotes uric acid restoration by activating hepatic AMPK pathway. Free Radic Biol Med. 2024;224:644\u201359.","journal-title":"Free Radic Biol Med"},{"key":"2049_CR120","unstructured":"Xiangcheng F, Guangyang J, Tao P, Tao W, Zhiqing H, Jun H et al. Ameliorative effects of mangiferin derivative TPX on insulin resistance via PI3K\/AKT and AMPK signaling pathways in human HepG2 and HL-7702 hepatocytes. Phytomedicine. 2023."},{"key":"2049_CR121","unstructured":"Xiaoming L, Kelly JP, Ahmad RS, Hong W, William D. Compound C stimulates Heme oxygenase-1 gene expression via the Nrf2-ARE pathway to preserve human endothelial cell survival. Biochem Pharmacol 2011."},{"key":"2049_CR122","doi-asserted-by":"crossref","first-page":"E1029","DOI":"10.1152\/ajpendo.90241.2008","volume":"296","author":"JF Ndisang","year":"2009","unstructured":"Ndisang JF, Lane N, Jadhav A. Upregulation of the Heme Oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes. Am J Physiol Endocrinol Metab. 2009;296:E1029\u201341.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2049_CR123","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.atherosclerosis.2008.07.021","volume":"203","author":"L-Y Lin","year":"2009","unstructured":"Lin L-Y, Kuo H-K, Hwang J-J, Lai L-P, Chiang F-T, Tseng C-D, et al. Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents. Atherosclerosis. 2009;203:563\u20138.","journal-title":"Atherosclerosis"},{"key":"2049_CR124","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/pedi.12102","volume":"15","author":"B Mianowska","year":"2014","unstructured":"Mianowska B, Kami\u0144ska A, Fendler W, Szadkowska A, M\u0142ynarski W. Bilirubin is an independent factor inversely associated with glycated hemoglobin level in pediatric patients with type 1 diabetes. Pediatr Diabetes. 2014;15:389\u201393.","journal-title":"Pediatr Diabetes"},{"key":"2049_CR125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/MPG.0b013e318291fefe","volume":"57","author":"K Puri","year":"2013","unstructured":"Puri K, Nobili V, Melville K, Corte CD, Sartorelli MR, Lopez R, et al. Serum bilirubin level is inversely associated with nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2013;57:114\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2049_CR126","volume-title":"Microvascular basement membranes in diabetes mellitus","author":"CT Effie","year":"2003","unstructured":"Effie CT. Microvascular basement membranes in diabetes mellitus. J. Pathol; 2003."},{"key":"2049_CR127","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s11255-018-1923-9","volume":"50","author":"K Uludag","year":"2018","unstructured":"Uludag K, Oguzhan N, Ar\u0131kan T, Boz G. Serum bilirubin level and its impact on the progression of chronic kidney disease. Int Urol Nephrol. 2018;50:1695\u2013701.","journal-title":"Int Urol Nephrol"},{"key":"2049_CR128","unstructured":"Ying W, Chaojie C, Jiajun C, Tingting S, Peng H, Xiaojian L et al. Overexpression of NAG-1\/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated DsDNA release and AIM2 inflammasome activation. Redox Biol 2022."},{"key":"2049_CR129","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1007\/s11033-023-08339-y","volume":"50","author":"O Vakili","year":"2023","unstructured":"Vakili O, Borji M, Saffari-Chaleshtori J, Shafiee SM. Ameliorative effects of bilirubin on cell culture model of non-alcoholic fatty liver disease. Mol Biol Rep. 2023;50:4411\u201322.","journal-title":"Mol Biol Rep"},{"key":"2049_CR130","unstructured":"Thierry H, Emmanuel LG. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol 2021."},{"key":"2049_CR131","doi-asserted-by":"crossref","first-page":"869579","DOI":"10.3389\/fendo.2022.869579","volume":"13","author":"C Liang","year":"2022","unstructured":"Liang C, Yu Z, Bai L, Hou W, Tang S, Zhang W, et al. Association of serum bilirubin with metabolic syndrome and Non-Alcoholic fatty liver disease: A systematic review and Meta-Analysis. Front Endocrinol (Lausanne). 2022;13:869579.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2049_CR132","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.atherosclerosis.2013.06.021","volume":"230","author":"SJ Kang","year":"2013","unstructured":"Kang SJ, Kim D, Park HE, Chung GE, Choi SH, Choi S-Y, et al. Elevated serum bilirubin levels are inversely associated with coronary artery atherosclerosis. Atherosclerosis. 2013;230:242\u20138.","journal-title":"Atherosclerosis"},{"key":"2049_CR133","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3350\/cmh.2012.18.4.383","volume":"18","author":"M-S Kwak","year":"2012","unstructured":"Kwak M-S, Kim D, Chung GE, Kang SJ, Park MJ, Kim YJ, et al. Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease. Clin Mol Hepatol. 2012;18:383.","journal-title":"Clin Mol Hepatol"},{"key":"2049_CR134","unstructured":"Parth T, Shuang W, Scott LF. The Power of Plasticity\u2014Metabolic Regulation of Hepatic Stellate Cells. Cell Metabolism. 2021."},{"key":"2049_CR135","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3892\/mmr.2017.6201","volume":"15","author":"Y Tang","year":"2017","unstructured":"Tang Y, Zhang Q, Zhu Y, Chen G, Yu F. Low concentrations of bilirubin inhibit activation of hepatic stellate cells in vitro. Mol Med Rep. 2017;15:1647\u201353.","journal-title":"Mol Med Rep"},{"key":"2049_CR136","unstructured":"Jongyoon S, Seojeong P, Seonju L, Nayoon P, Seojeong K, Seohui H, et al. Antioxidative hyaluronic Acid\u2013Bilirubin nanomedicine targeting activated hepatic stellate cells for Anti-Hepatic-Fibrosis therapy. ACS Nano; 2024."},{"key":"2049_CR137","doi-asserted-by":"crossref","unstructured":"Xudong S, Junyu S, Jieting L, Yong L, Yang Y, Yufei Q et al. Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via Inhibition of TGF-\u03b2\/Smad pathway. Mol Med 2022.","DOI":"10.1186\/s10020-022-00508-2"},{"key":"2049_CR138","unstructured":"Sergio Claudio S, Filippo P, Stefano G, Gianluca M, Carlo Alberto C, Alberto I. Common aspects between glaucoma and brain neurodegeneration. Mutation Research\/Reviews in Mutation Research; 2020."},{"key":"2049_CR139","unstructured":"Ye T, Yongmei Q, Hui C, Mengchen X, Yingmei Z. Senegenin alleviates A\u03b21\u201342 induced cell damage through triggering mitophagy. J Ethnopharmacol 2022."},{"key":"2049_CR140","unstructured":"Catalina N, Paulina S, Pedro C, Camila G, Roberto FV-S, Juan MZ et al. Inflammation context in Alzheimer\u2019s disease, a relationship intricate to define. Biol Res 2022."},{"key":"2049_CR141","unstructured":"Patricia GR, Enrico Z, Kristen AS, Josefina G, Ema I, Ben Y et al. Disruption of mitochondrial complex I induces progressive parkinsonism. Nature 2021."},{"key":"2049_CR142","volume-title":"Modulation of bilirubin neurotoxicity by the Abcb1 transporter in theUgt1-\/-lethal mouse model of neonatal hyperbilirubinemia","author":"B Luka","year":"2016","unstructured":"Luka B, Giulia B, Simone V, Alessandra I, Jana J, Jaroslav Z, et al. Modulation of bilirubin neurotoxicity by the Abcb1 transporter in theUgt1-\/-lethal mouse model of neonatal hyperbilirubinemia. Hum Mol Genet; 2016."},{"key":"2049_CR143","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12987-022-00332-0","volume":"19","author":"S Blondel","year":"2022","unstructured":"Blondel S, Strazielle N, Amara A, Guy R, Bain C, Rose A, et al. Vascular network expansion, integrity of blood\u2013brain interfaces, and cerebrospinal fluid cytokine concentration during postnatal development in the normal and jaundiced rat. Fluids Barriers CNS. 2022;19:47.","journal-title":"Fluids Barriers CNS"},{"key":"2049_CR144","doi-asserted-by":"crossref","first-page":"111028","DOI":"10.1016\/j.brainresbull.2024.111028","volume":"215","author":"Y Gao","year":"2024","unstructured":"Gao Y, Ling Y, Li J, Xu Y, Ge J, Xia Q. Neuropathological implication of high blood bilirubin in patients and model rats with depression. Brain Res Bull. 2024;215:111028.","journal-title":"Brain Res Bull"},{"key":"2049_CR145","unstructured":"Thor Willy Ruud H. Bilirubin oxidation in brain. Molecular Genetics and Metabolism; 2000."},{"key":"2049_CR146","doi-asserted-by":"crossref","unstructured":"Brites D. The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation. Front Pharmacol 2012; 3.","DOI":"10.3389\/fphar.2012.00088"},{"key":"2049_CR147","unstructured":"Faiza K, Suman R, Caroline S, Shuchita G. Universal screening for hyperbilirubinemia in term healthy newborns at discharge: A systematic review and meta-analysis. J Global Health 2022."},{"key":"2049_CR148","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2174\/1573396313666170718150056","volume":"13","author":"F Ebbesen","year":"2017","unstructured":"Ebbesen F, Hansen TW, Maisels MJ. Update on phototherapy in jaundiced neonates. Curr Pediatr Rev. 2017;13:176\u201380.","journal-title":"Curr Pediatr Rev"},{"key":"2049_CR149","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1542\/peds.113.1.119","volume":"113","author":"A Kappas","year":"2004","unstructured":"Kappas A. A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin. Pediatrics. 2004;113:119\u201323.","journal-title":"Pediatrics"},{"key":"2049_CR150","unstructured":"Arnon K, David A. Sa.35. BDNF Production by Immune Cells of Relapsing Remitting Multiple Sclerosis Is Reduced and Is Not Responsive to Cd40 Stimulation. Clin Immunol. 2006."},{"key":"2049_CR151","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1021\/acs.molpharmaceut.0c00337","volume":"17","author":"Z Chen","year":"2020","unstructured":"Chen Z, Vong CT, Gao C, Chen S, Wu X, Wang S, et al. Bilirubin nanomedicines for the treatment of reactive oxygen species (ROS)-Mediated diseases. Mol Pharm. 2020;17:2260\u201374.","journal-title":"Mol Pharm"},{"key":"2049_CR152","doi-asserted-by":"crossref","unstructured":"Thomas DT, DelCimmuto NR, Flack KD, Stec DE, Hinds TD. Jr. Reactive oxygen species (ROS) and antioxidants as immunomodulators in exercise: implications for Heme oxygenase and bilirubin. Antioxid (Basel) 2022; 11.","DOI":"10.3390\/antiox11020179"},{"key":"2049_CR153","unstructured":"Abigail SK, Heather RC. Division enzyme regulates metabolism. Nature 2017."},{"key":"2049_CR154","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/cbin.10592","volume":"40","author":"J Yin","year":"2016","unstructured":"Yin J, Sheng B, Han B, Pu A, Yang K, Li P, et al. The AhR is involved in the regulation of LoVo cell proliferation through cell cycle-associated proteins. Cell Biol Int. 2016;40:560\u20138.","journal-title":"Cell Biol Int"},{"key":"2049_CR155","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1038\/sj.onc.1205633","volume":"21","author":"A Koliopanos","year":"2002","unstructured":"Koliopanos A, Kleeff J, Xiao Y, Safe S, Zimmermann A, B\u00fcchler MW, et al. Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer. Oncogene. 2002;21:6059\u201370.","journal-title":"Oncogene"},{"key":"2049_CR156","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.15252\/embr.201439245","volume":"15","author":"BG Childs","year":"2014","unstructured":"Childs BG, Baker DJ, Kirkland JL, Campisi J, Van Deursen JM. Senescence and apoptosis: dueling or complementary cell fates? EMBO Rep. 2014;15:1139\u201353.","journal-title":"EMBO Rep"},{"key":"2049_CR157","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12916-020-01703-w","volume":"18","author":"N Seyed Khoei","year":"2020","unstructured":"Seyed Khoei N, Jenab M, Murphy N, Banbury BL, Carreras-Torres R, Viallon V, et al. Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses. BMC Med. 2020;18:229.","journal-title":"BMC Med"},{"key":"2049_CR158","first-page":"691","volume":"305","author":"LJ Horsfall","year":"2011","unstructured":"Horsfall LJ, Rait G, Walters K, Swallow DM, Pereira SP, Nazareth I, et al. Serum Bilirubin Risk Respiratory Disease Death JAMA. 2011;305:691\u20137.","journal-title":"Serum Bilirubin Risk Respiratory Disease Death JAMA"},{"key":"2049_CR159","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0016-5085(84)90705-4","volume":"87","author":"M Muraca","year":"1984","unstructured":"Muraca M, Fevery J. Influence of sex and sex steroids on bilirubin uridine diphosphate-glucuronosyltransferase activity of rat liver. Gastroenterology. 1984;87:308\u201313.","journal-title":"Gastroenterology"},{"key":"2049_CR160","volume-title":"Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis","author":"L-M Eneritz","year":"2023","unstructured":"Eneritz L-M, Carlos M. Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis. J.Mol.Sci; 2023."},{"key":"2049_CR161","doi-asserted-by":"crossref","unstructured":"Arnold M, Stefan R, Michael S, Christoph B, Carol H, Ulf ML et al. POS1035 Focal adhesion proteins kindlin-1, -2 and talin-1 are regulated in il-1\u03b2-stimulated rheumatoid arthritis synovial fibroblasts. null 2023.","DOI":"10.1136\/annrheumdis-2023-eular.3477"},{"key":"2049_CR162","first-page":"256","volume":"2","author":"D Fischman","year":"2010","unstructured":"Fischman D, Valluri A, Gorrepati VS, Murphy ME, Peters I, Cheriyath P. Bilirubin as a protective factor for rheumatoid arthritis: an NHANES study of 2003\u20132006 data. J Clin Med Res. 2010;2:256\u201360.","journal-title":"J Clin Med Res"},{"key":"2049_CR163","doi-asserted-by":"crossref","first-page":"F552","DOI":"10.1152\/ajprenal.00278.2004","volume":"288","author":"A Pflueger","year":"2005","unstructured":"Pflueger A, Croatt AJ, Peterson TE, Smith LA, d\u2019Uscio LV, Katusic ZS, et al. The hyperbilirubinemic Gunn rat is resistant to the pressor effects of angiotensin II. Am J Physiol Ren Physiol. 2005;288:F552\u20138.","journal-title":"Am J Physiol Ren Physiol"},{"key":"2049_CR164","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/S0021-9258(17)30230-2","volume":"254","author":"R Brodersen","year":"1979","unstructured":"Brodersen R, Bilirubin. Solubility and interaction with albumin and phospholipid. J Biol Chem. 1979;254:2364\u20139.","journal-title":"J Biol Chem"},{"key":"2049_CR165","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/14756366.2021.2020773","volume":"37","author":"A Nocentini","year":"2022","unstructured":"Nocentini A, Bonardi A, Pratesi S, Gratteri P, Dani C, Supuran CT. Pharmaceutical strategies for preventing toxicity and promoting antioxidant and anti-inflammatory actions of bilirubin. J Enzyme Inhib Med Chem. 2022;37:487\u2013501.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"2049_CR166","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biomaterials.2017.06.014","volume":"140","author":"DE Kim","year":"2017","unstructured":"Kim DE, Lee Y, Kim M, Lee S, Jon S, Lee S-H. Bilirubin nanoparticles ameliorate allergic lung inflammation in a mouse model of asthma. Biomaterials. 2017;140:37\u201344.","journal-title":"Biomaterials"},{"key":"2049_CR167","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jconrel.2020.03.034","volume":"322","author":"Q Yao","year":"2020","unstructured":"Yao Q, Jiang X, Zhai Y-Y, Luo L-Z, Xu H-L, Xiao J, et al. Protective effects and mechanisms of bilirubin nanomedicine against acute pancreatitis. J Controlled Release. 2020;322:312\u201325.","journal-title":"J Controlled Release"},{"key":"2049_CR168","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1177\/0963689717735112","volume":"26","author":"B Fullagar","year":"2017","unstructured":"Fullagar B, Rao W, Gilor C, Xu F, He X, Adin CA. Nano-encapsulation of bilirubin in pluronic F127\u2013chitosan improves uptake in \u0392 cells and increases islet viability and function after hypoxic stress. Cell Transplant. 2017;26:1703\u201315.","journal-title":"Cell Transplant"},{"key":"2049_CR169","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.biomaterials.2017.04.029","volume":"133","author":"MJ Kim","year":"2017","unstructured":"Kim MJ, Lee Y, Jon S, Lee DY. PEGylated bilirubin nanoparticle as an anti-oxidative and anti-inflammatory demulcent in pancreatic islet xenotransplantation. Biomaterials. 2017;133:242\u201352.","journal-title":"Biomaterials"},{"key":"2049_CR170","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1021\/acsami.9b18986","volume":"12","author":"Q Yao","year":"2020","unstructured":"Yao Q, Huang Z-W, Zhai Y-Y, Yue M, Luo L-Z, Xue P-P, et al. Localized controlled release of bilirubin from \u03b2-cyclodextrin-conjugated \u03b5-polylysine to attenuate oxidative stress and inflammation in transplanted Islets. ACS Appl Mater Interfaces. 2020;12:5462\u201375.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2049_CR171","doi-asserted-by":"crossref","first-page":"13872","DOI":"10.1002\/ange.201707137","volume":"129","author":"DY Lee","year":"2017","unstructured":"Lee DY, Kim JY, Lee Y, Lee S, Miao W, Kim HS, et al. Black pigment gallstone inspired platinum-chelated bilirubin nanoparticles for combined photoacoustic imaging and photothermal therapy of cancers. Angew Chem. 2017;129:13872\u20136.","journal-title":"Angew Chem"},{"key":"2049_CR172","doi-asserted-by":"crossref","first-page":"7690","DOI":"10.1021\/acsnano.9b01201","volume":"13","author":"P Fathi","year":"2019","unstructured":"Fathi P, Knox HJ, Sar D, Tripathi I, Ostadhossein F, Misra SK, et al. Biodegradable biliverdin nanoparticles for efficient photoacoustic imaging. ACS Nano. 2019;13:7690\u2013704.","journal-title":"ACS Nano"},{"key":"2049_CR173","doi-asserted-by":"crossref","first-page":"1900822","DOI":"10.1002\/adma.201900822","volume":"31","author":"R Xing","year":"2019","unstructured":"Xing R, Zou Q, Yuan C, Zhao L, Chang R, Yan X. Self-Assembling endogenous biliverdin as a versatile Near-Infrared photothermal nanoagent for Cancer theranostics. Adv Mater. 2019;31:1900822.","journal-title":"Adv Mater"},{"key":"2049_CR174","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41563-019-0462-9","volume":"19","author":"Y Lee","year":"2020","unstructured":"Lee Y, Sugihara K, Gillilland MG, Jon S, Kamada N, Moon JJ. Hyaluronic acid\u2013bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, Microbiome and immune responses in colitis. Nat Mater. 2020;19:118\u201326.","journal-title":"Nat Mater"},{"key":"2049_CR175","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1021\/acs.biomac.8b00189","volume":"19","author":"S Lee","year":"2018","unstructured":"Lee S, Lee Y, Kim H, Lee DY, Jon S. Bilirubin Nanoparticle-Assisted delivery of a small Molecule-Drug conjugate for targeted Cancer therapy. Biomacromolecules. 2018;19:2270\u20137.","journal-title":"Biomacromolecules"},{"key":"2049_CR176","doi-asserted-by":"crossref","first-page":"1800017","DOI":"10.1002\/advs.201800017","volume":"5","author":"Y Lee","year":"2018","unstructured":"Lee Y, Lee S, Jon S. Biotinylated bilirubin nanoparticles as a tumor Microenvironment-Responsive drug delivery system for targeted Cancer therapy. Adv Sci. 2018;5:1800017.","journal-title":"Adv Sci"},{"key":"2049_CR177","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1021\/acsami.8b16219","volume":"11","author":"M Yu","year":"2019","unstructured":"Yu M, Su D, Yang Y, Qin L, Hu C, Liu R, et al. D-T7 Peptide-Modified pegylated bilirubin nanoparticles loaded with cediranib and Paclitaxel for antiangiogenesis and chemotherapy of glioma. ACS Appl Mater Interfaces. 2019;11:176\u201386.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2049_CR178","doi-asserted-by":"crossref","first-page":"10676","DOI":"10.1002\/anie.201604858","volume":"55","author":"Y Lee","year":"2016","unstructured":"Lee Y, Lee S, Lee DY, Yu B, Miao W, Jon S. Multistimuli-Responsive bilirubin nanoparticles for anticancer therapy. Angew Chem Int Ed. 2016;55:10676\u201380.","journal-title":"Angew Chem Int Ed"},{"key":"2049_CR179","doi-asserted-by":"crossref","first-page":"8903","DOI":"10.1021\/acsnano.9b02477","volume":"13","author":"L Shan","year":"2019","unstructured":"Shan L, Fan W, Wang W, Tang W, Yang Z, Wang Z, et al. Organosilica-Based Hollow mesoporous bilirubin nanoparticles for Antioxidation-Activated Self-Protection and Tumor-Specific Deoxygenation-Driven synergistic therapy. ACS Nano. 2019;13:8903\u201316.","journal-title":"ACS Nano"},{"key":"2049_CR180","unstructured":"Varun S, Erdost Y, Andr\u00e9s RC, Xianglong L, Liang Y, Paul W et al. Designing covalent organic Framework-based Light\u2010driven microswimmers towards therapeutic applications. Adv Mater 2023."},{"key":"2049_CR181","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jconrel.2021.04.033","volume":"334","author":"ZW Huang","year":"2021","unstructured":"Huang ZW, Shi Y, Zhai YY, Du CC, Zhai J, Yu RJ, et al. Hyaluronic acid coated bilirubin nanoparticles attenuate ischemia reperfusion-induced acute kidney injury. J Control Release. 2021;334:275\u201389.","journal-title":"J Control Release"},{"key":"2049_CR182","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s11239-016-1440-6","volume":"43","author":"H Bardania","year":"2017","unstructured":"Bardania H, Shojaosadati SA, Kobarfard F, Dorkoosh F, Zadeh ME, Naraki M, et al. Encapsulation of Eptifibatide in RGD-modified nanoliposomes improves platelet aggregation inhibitory activity. J Thromb Thrombolysis. 2017;43:184\u201393.","journal-title":"J Thromb Thrombolysis"},{"key":"2049_CR183","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijpharm.2019.04.025","volume":"564","author":"M Baneshi","year":"2019","unstructured":"Baneshi M, Dadfarnia S, Shabani AMH, Sabbagh SK, Haghgoo S, Bardania H. A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery. Int J Pharm. 2019;564:145\u201352.","journal-title":"Int J Pharm"},{"key":"2049_CR184","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/14728222.2018.1502273","volume":"22","author":"L Kou","year":"2018","unstructured":"Kou L, Sun R, Ganapathy V, Yao Q, Chen R. Recent advances in drug delivery via the organic cation\/carnitine transporter 2 (OCTN2\/SLC22A5). Expert Opin Ther Targets. 2018;22:715\u201326.","journal-title":"Expert Opin Ther Targets"},{"key":"2049_CR185","doi-asserted-by":"crossref","first-page":"30031","DOI":"10.1021\/acsami.0c03564","volume":"12","author":"L Kou","year":"2020","unstructured":"Kou L, Sun R, Jiang X, Lin X, Huang H, Bao S, et al. Tumor Microenvironment-Responsive, multistaged liposome induces apoptosis and ferroptosis by amplifying oxidative stress for enhanced Cancer therapy. ACS Appl Mater Interfaces. 2020;12:30031\u201343.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2049_CR186","doi-asserted-by":"crossref","first-page":"10996","DOI":"10.1021\/acsnano.3c03252","volume":"17","author":"AT Rahman","year":"2023","unstructured":"Rahman AT, Shin J, Whang CH, Jung W, Yoo D, Seo C, et al. Bilirubin nanomedicine rescues intestinal barrier destruction and restores mucosal immunity in colitis. ACS Nano. 2023;17:10996\u20131013.","journal-title":"ACS Nano"},{"key":"2049_CR187","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jconrel.2020.07.015","volume":"325","author":"H Keum","year":"2020","unstructured":"Keum H, Kim TW, Kim Y, Seo C, Son Y, Kim J, et al. Bilirubin nanomedicine alleviates psoriatic skin inflammation by reducing oxidative stress and suppressing pathogenic signaling. J Control Release. 2020;325:359\u201369.","journal-title":"J Control Release"},{"key":"2049_CR188","doi-asserted-by":"crossref","first-page":"528","DOI":"10.7150\/thno.87739","volume":"14","author":"Z Zhuo","year":"2024","unstructured":"Zhuo Z, Guo K, Luo Y, Yang Q, Wu H, Zeng R, et al. Targeted modulation of intestinal epithelial regeneration and immune response in ulcerative colitis using dual-targeting bilirubin nanoparticles. Theranostics. 2024;14:528\u201346.","journal-title":"Theranostics"},{"key":"2049_CR189","doi-asserted-by":"crossref","first-page":"7460","DOI":"10.1002\/anie.201602525","volume":"55","author":"Y Lee","year":"2016","unstructured":"Lee Y, Kim H, Kang S, Lee J, Park J, Jon S. Bilirubin nanoparticles as a nanomedicine for Anti-inflammation therapy. Angew Chem Int Ed. 2016;55:7460\u20133.","journal-title":"Angew Chem Int Ed"},{"key":"2049_CR190","doi-asserted-by":"crossref","first-page":"e2305830","DOI":"10.1002\/adma.202305830","volume":"36","author":"W Jung","year":"2024","unstructured":"Jung W, Asaduddin M, Keum H, Son Y, Yoo D, Kim D, et al. Longitudinal magnetic resonance imaging with ROS-Responsive bilirubin nanoparticles enables monitoring of nonalcoholic steatohepatitis progression to cirrhosis. Adv Mater. 2024;36:e2305830.","journal-title":"Adv Mater"},{"key":"2049_CR191","unstructured":"Angeliki PK, Karyofyllis T, Paramithiotis D, Katerina K, Panos NK. Effect of a novel NSAID derivative with antioxidant moiety on oxidative damage caused by liver and cerebral ischaemia-reperfusion in rats. J Pharm Pharmacol 2002."},{"key":"2049_CR192","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1016\/S0021-9258(18)63479-9","volume":"244","author":"MG Mustafa","year":"1969","unstructured":"Mustafa MG, Cowger ML, King TE. Effects of bilirubin on mitochondrial reactions. J Biol Chem. 1969;244:6403\u201314.","journal-title":"J Biol Chem"},{"key":"2049_CR193","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1126\/science.155.3767.1288","volume":"155","author":"I Diamond","year":"1967","unstructured":"Diamond I, Schmid R. Oxidative phosphorylation in experimental bilirubin encephalopathy. Science. 1967;155:1288\u20139.","journal-title":"Science"},{"key":"2049_CR194","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0006-8993(75)90860-4","volume":"83","author":"R Katoh","year":"1975","unstructured":"Katoh R, Kashiwamata S, Niwa F. Studies on cellular toxicity of bilirubin: effect on the carbohydrate metabolism in the young rat brain. Brain Res. 1975;83:81\u201392.","journal-title":"Brain Res"},{"key":"2049_CR195","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-510X(74)90056-2","volume":"22","author":"S Greenfield","year":"1974","unstructured":"Greenfield S, Nandi Majumdar AP. Bilirubin encephalopathy: effect on protein synthesis in the brain of the Gunn rat. J Neurol Sci. 1974;22:83\u20139.","journal-title":"J Neurol Sci"},{"key":"2049_CR196","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.atherosclerosis.2012.06.002","volume":"223","author":"M Hu","year":"2012","unstructured":"Hu M, Tomlinson B. Effects of Statin treatments and polymorphisms in UGT1A1 and SLCO1B1 on serum bilirubin levels in Chinese patients with hypercholesterolaemia. Atherosclerosis. 2012;223:427\u201332.","journal-title":"Atherosclerosis"},{"key":"2049_CR197","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1194\/jlr.P013193","volume":"52","author":"PRW de Sauvage Nolting","year":"2011","unstructured":"de Sauvage Nolting PRW, Kusters DM, Hutten BA, Kastelein JJP, for the Ex Psg. Serum bilirubin levels in Familial hypercholesterolemia: a new risk marker for cardiovascular disease? J Lipid Res. 2011;52:1755\u20139.","journal-title":"J Lipid Res"},{"key":"2049_CR198","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm.3708","volume":"20","author":"A Sistigu","year":"2014","unstructured":"Sistigu A, Yamazaki T, Vacchelli E, Chaba K, Enot DP, Adam J, et al. Cancer cell\u2013autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nat Med. 2014;20:1301\u20139.","journal-title":"Nat Med"},{"key":"2049_CR199","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1158\/0008-5472.CAN-12-4241","volume":"73","author":"TH Kang","year":"2013","unstructured":"Kang TH, Mao C-P, Lee SY, Chen A, Lee J-H, Kim TW, et al. Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for Vaccination-Induced antitumor immunity. Cancer Res. 2013;73:2493\u2013504.","journal-title":"Cancer Res"},{"key":"2049_CR200","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.neo.2015.08.004","volume":"17","author":"J Rios-Doria","year":"2015","unstructured":"Rios-Doria J, Durham N, Wetzel L, Rothstein R, Chesebrough J, Holoweckyj N, et al. Doxil synergizes with Cancer immunotherapies to enhance antitumor responses in syngeneic mouse models. Neoplasia. 2015;17:661\u201370.","journal-title":"Neoplasia"},{"key":"2049_CR201","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1038\/s41467-023-40270-5","volume":"14","author":"Y Lee","year":"2023","unstructured":"Lee Y, Shinn J, Xu C, Dobson HE, Neamati N, Moon JJ. Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy. Nat Commun. 2023;14:4771.","journal-title":"Nat Commun"},{"key":"2049_CR202","doi-asserted-by":"crossref","first-page":"1901896","DOI":"10.1002\/adfm.201901896","volume":"29","author":"X Yang","year":"2019","unstructured":"Yang X, Hu C, Tong F, Liu R, Zhou Y, Qin L, et al. Tumor Microenvironment-Responsive dual drug Dimer-Loaded pegylated bilirubin nanoparticles for improved drug delivery and enhanced Immune-Chemotherapy of breast Cancer. Adv Funct Mater. 2019;29:1901896.","journal-title":"Adv Funct Mater"},{"key":"2049_CR203","doi-asserted-by":"crossref","first-page":"1808462","DOI":"10.1002\/adfm.201808462","volume":"29","author":"R Liu","year":"2019","unstructured":"Liu R, Yu M, Yang X, Umeshappa CS, Hu C, Yu W, et al. Linear chimeric triblock molecules Self-Assembled micelles with controllably transformable property to enhance tumor retention for Chemo-Photodynamic therapy of breast Cancer. Adv Funct Mater. 2019;29:1808462.","journal-title":"Adv Funct Mater"},{"key":"2049_CR204","doi-asserted-by":"crossref","first-page":"e67771","DOI":"10.1371\/journal.pone.0067771","volume":"8","author":"R Gonzalo-Gobernado","year":"2013","unstructured":"Gonzalo-Gobernado R, Calatrava-Ferreras L, Reimers D, Herranz AS, Rodriguez-Serrano M, Miranda C, et al. Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson\u2019s disease. PLoS ONE. 2013;8:e67771.","journal-title":"PLoS ONE"},{"key":"2049_CR205","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.3390\/molecules26082315","volume":"26","author":"E Goya-Jorge","year":"2021","unstructured":"Goya-Jorge E, Jorge Rodr\u00edguez ME, Veit\u00eda MS-I, Giner RM. Plant occurring flavonoids as modulators of the Aryl hydrocarbon receptor. Molecules. 2021;26:2315.","journal-title":"Molecules"},{"key":"2049_CR206","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1289\/ehp.6322","volume":"111","author":"S Zhang","year":"2003","unstructured":"Zhang S, Qin C, Safe SH. Flavonoids as Aryl hydrocarbon receptor agonists\/antagonists: effects of structure and cell context. Environ Health Perspect. 2003;111:1877\u201382.","journal-title":"Environ Health Perspect"},{"key":"2049_CR207","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1042\/bj3400715","volume":"340","author":"HP Ciolino","year":"1999","unstructured":"CIOLINO HP, DASCHNER PJ. Dietary flavonols Quercetin and Kaempferol are ligands of the Aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem J. 1999;340:715\u201322.","journal-title":"Biochem J"},{"key":"2049_CR208","doi-asserted-by":"crossref","unstructured":"Consonni FM, Incerti M, Bertolotti M, Ballerini G, Garlatti V, Sica A. Heme catabolism and Heme oxygenase-1-expressing myeloid cells in pathophysiology. Front Immunol 2024; 15.","DOI":"10.3389\/fimmu.2024.1433113"},{"key":"2049_CR209","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/1753-0407.13356","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Qi H, Wang L, Hu C, Gao A, Wu Q, et al. Fasting and refeeding triggers specific changes in bile acid profiles and gut microbiota. J Diabetes. 2023;15:165\u201380.","journal-title":"J Diabetes"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02049-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02049-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02049-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:53:23Z","timestamp":1767200003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02049-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":209,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2049"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02049-w","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"26 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicapble.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"81"}}